Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Opthea Limited, a clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States. Its development activities are based on the intellectual property portfolio covering vascular endothelial growth factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company's lead product candidate is sozinibercept (OPT-302), a biologic drug in Phase 3 clinical trials designed to inhibit VEGF-C and VEGF-D and complement VEGF-A inhibitors for the treatment of wet age-related macular degeneration and diabetic macular edema. It serves the biotechnology and healthcare industries. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is headquartered in South Yarra, Australia. more
Time Frame | OPT | Sector | S&P500 |
---|---|---|---|
1-Week Return | -9.59% | -2.82% | 0.15% |
1-Month Return | -20.02% | -4.22% | 1.78% |
3-Month Return | 4.76% | -9.52% | 8.7% |
6-Month Return | 68.8% | -3.45% | 12.24% |
1-Year Return | 34.69% | 5.62% | 30.9% |
3-Year Return | -53.72% | 3.8% | 30.19% |
5-Year Return | -79.83% | 39.68% | 91.72% |
10-Year Return | -34.46% | 105.02% | 203.2% |
Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 59.06K | 91.98K | 125.05K | 161.16K | 124.67K | [{"date":"2020-06-30","value":36.65,"profit":true},{"date":"2021-06-30","value":57.07,"profit":true},{"date":"2022-06-30","value":77.59,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":77.35,"profit":true}] |
Cost of Revenue | 517.26K | 571.98K | 232.47K | 250.47K | 240.14K | [{"date":"2020-06-30","value":90.43,"profit":true},{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":40.64,"profit":true},{"date":"2023-06-30","value":43.79,"profit":true},{"date":"2024-06-30","value":41.98,"profit":true}] |
Gross Profit | (458.20K) | (480.00K) | (107.42K) | (89.31K) | 124.67K | [{"date":"2020-06-30","value":-367.54,"profit":false},{"date":"2021-06-30","value":-385.03,"profit":false},{"date":"2022-06-30","value":-86.17,"profit":false},{"date":"2023-06-30","value":-71.64,"profit":false},{"date":"2024-06-30","value":100,"profit":true}] |
Gross Margin | (775.81%) | (521.85%) | (85.91%) | (55.42%) | 100.00% | [{"date":"2020-06-30","value":-775.81,"profit":false},{"date":"2021-06-30","value":-521.85,"profit":false},{"date":"2022-06-30","value":-85.91,"profit":false},{"date":"2023-06-30","value":-55.42,"profit":false},{"date":"2024-06-30","value":100,"profit":true}] |
Operating Expenses | 17.02M | 53.13M | 133.29M | 223.46M | 191.97M | [{"date":"2020-06-30","value":7.62,"profit":true},{"date":"2021-06-30","value":23.78,"profit":true},{"date":"2022-06-30","value":59.65,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":85.91,"profit":true}] |
Operating Income | 59.06K | (53.18M) | (133.27M) | (223.45M) | (191.84M) | [{"date":"2020-06-30","value":100,"profit":true},{"date":"2021-06-30","value":-90041.52,"profit":false},{"date":"2022-06-30","value":-225648.19,"profit":false},{"date":"2023-06-30","value":-378336.4,"profit":false},{"date":"2024-06-30","value":-324821.34,"profit":false}] |
Total Non-Operating Income/Expense | 978.23K | (13.86M) | (3.17M) | (80.90M) | (64.68M) | [{"date":"2020-06-30","value":100,"profit":true},{"date":"2021-06-30","value":-1416.59,"profit":false},{"date":"2022-06-30","value":-324.16,"profit":false},{"date":"2023-06-30","value":-8270.04,"profit":false},{"date":"2024-06-30","value":-6611.93,"profit":false}] |
Pre-Tax Income | (16.80M) | (67.41M) | (136.68M) | (220.69M) | (229.65M) | [{"date":"2020-06-30","value":-1680115900,"profit":false},{"date":"2021-06-30","value":-6740894900,"profit":false},{"date":"2022-06-30","value":-13667659400,"profit":false},{"date":"2023-06-30","value":-22069116000,"profit":false},{"date":"2024-06-30","value":-22965430100,"profit":false}] |
Income Taxes | (5.72M) | (6.62M) | (8.69M) | (8.81M) | (9.41M) | [{"date":"2020-06-30","value":-572037500,"profit":false},{"date":"2021-06-30","value":-662092800,"profit":false},{"date":"2022-06-30","value":-868638000,"profit":false},{"date":"2023-06-30","value":-881047900,"profit":false},{"date":"2024-06-30","value":-941219600,"profit":false}] |
Income After Taxes | (11.08M) | (60.79M) | (127.99M) | (211.88M) | (220.24M) | [{"date":"2020-06-30","value":-1108078400,"profit":false},{"date":"2021-06-30","value":-6078802100,"profit":false},{"date":"2022-06-30","value":-12799021400,"profit":false},{"date":"2023-06-30","value":-21188068100,"profit":false},{"date":"2024-06-30","value":-22024210500,"profit":false}] |
Income From Continuous Operations | (16.53M) | (45.34M) | (92.82M) | (142.52M) | (220.24M) | [{"date":"2020-06-30","value":-1652928100,"profit":false},{"date":"2021-06-30","value":-4534449600,"profit":false},{"date":"2022-06-30","value":-9281737100,"profit":false},{"date":"2023-06-30","value":-14252108500,"profit":false},{"date":"2024-06-30","value":-22024210500,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] |
Net Income | (11.08M) | (60.79M) | (127.99M) | (211.88M) | (220.24M) | [{"date":"2020-06-30","value":-1108078300,"profit":false},{"date":"2021-06-30","value":-6078802000,"profit":false},{"date":"2022-06-30","value":-12799021400,"profit":false},{"date":"2023-06-30","value":-21188068000,"profit":false},{"date":"2024-06-30","value":-22024210500,"profit":false}] |
EPS (Diluted) | (0.77) | 0.67 | (0.37) | (2.70) | (3.14) | [{"date":"2020-06-30","value":-114.36,"profit":false},{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":-55.22,"profit":false},{"date":"2023-06-30","value":-403.24,"profit":false},{"date":"2024-06-30","value":-468.66,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
OPT | |
---|---|
Cash Ratio | 2.69 |
Current Ratio | 2.94 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
OPT | |
---|---|
ROA (LTM) | -83.43% |
ROE (LTM) | -3383.08% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
OPT | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 1.40 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.40 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
OPT | |
---|---|
Trailing PE | NM |
Forward PE | 6.73 |
P/S (TTM) | 2050.97 |
P/B | 4.31 |
Price/FCF | NM |
EV/R | 3971.13 |
EV/Ebitda | NM |
Opthea Ltd (OPT) share price today is $3.3
Yes, Indians can buy shares of Opthea Ltd (OPT) on Vested. To buy Opthea Ltd from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in OPT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Opthea Ltd (OPT) via the Vested app. You can start investing in Opthea Ltd (OPT) with a minimum investment of $1.
You can invest in shares of Opthea Ltd (OPT) via Vested in three simple steps:
The 52-week high price of Opthea Ltd (OPT) is $5.45. The 52-week low price of Opthea Ltd (OPT) is $1.79.
The price-to-earnings (P/E) ratio of Opthea Ltd (OPT) is
The price-to-book (P/B) ratio of Opthea Ltd (OPT) is 4.31
The dividend yield of Opthea Ltd (OPT) is 0.00%
The market capitalization of Opthea Ltd (OPT) is $555.40M
The stock symbol (or ticker) of Opthea Ltd is OPT